[HTML][HTML] Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19

J Ma, P Xia, Y Zhou, Z Liu, X Zhou, J Wang… - Clinical Immunology …, 2020 - ncbi.nlm.nih.gov
We described three critically ill patients with coronavirus disease 2019 (COVID-19) in
Wuhan, China, featured with profound inflammation and treated with blood purification …

[HTML][HTML] Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient

G Monneret, D de Marignan, R Coudereau… - Cellular & molecular …, 2020 - nature.com
One of the immune characteristics of coronavirus disease 2019 (COVID-19) is a massive fall
in lymphocyte count in which magnitude associates with mortality. 1, 2 Recent monitoring of …

Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe coronavirus disease 2019 (COVID-19)

PF Laterre, B François, C Collienne… - JAMA network …, 2020 - jamanetwork.com
Cytokine storm–mediated organ injury continues to dominate current thinking as the primary
mechanism for coronavirus disease 2019 (COVID-19). Although there is an initial hyper …

Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19

H Shi, C Zhou, P He, S Huang, Y Duan, X Wang… - International journal of …, 2020 - Elsevier
Here we report a case of a laboratory-confirmed 2019 novel coronavirus (2019-nCoV)-
infected patient with COVID-19 (coronavirus disease 2019) who developed respiratory …

The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure

P Keith, M Day, C Choe, L Perkins… - SAGE open medical …, 2020 - journals.sagepub.com
The COVID-19 pandemic has brought about an urgent need for effective treatment, while
conserving vital resources such as intensive care unit beds and ventilators. Antivirals …

[HTML][HTML] Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19

Y Liu, W Tan, H Chen, Y Zhu, L Wan, K Jiang… - BMC infectious …, 2021 - Springer
Background The lack of knowledge regarding the pathogenesis and host immune response
during SARS-CoV-2 infection has limited the development of effective treatments. Thus, we …

[HTML][HTML] Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression

R Jeannet, T Daix, R Formento, J Feuillard… - Intensive care …, 2020 - Springer
Dear Editor, SARS-CoV-2 infection is associated with marked lymphopenia that correlates
with morbidity and mortality [1, 2]. Here, we present the first report on serial …

Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China

XU Bo, C Fan, A Wang, Y Zou, Y Yu, HE Cong, W Xia… - Journal of Infection, 2020 - Elsevier
Importance An ongoing outbreak of COVID-19 has exhibited significant threats around the
world. We found a significant decrease of T lymphocyte subsets and an increase of …

[HTML][HTML] Immune characteristics of severe and critical COVID-19 patients

L Yang, J Gou, J Gao, L Huang, Z Zhu, S Ji… - Signal transduction and …, 2020 - nature.com
Recently, the novel coronavirus disease (COVID-19) has broken out worldwide, 1 with rapid
increase of infected patients. COVID-19 dominantly leads to pneumonia. 2 Among these …

[PDF][PDF] Cytokine-targeted therapy in severely ill COVID-19 patients: options and cautions

M Rahmati, MA Moosavi - mortality, 2020 - researchgate.net
Dear Editor, Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) with the symptoms …